Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
7.55
-0.82 (-9.80%)
At close: Jun 20, 2025, 4:00 PM
7.92
+0.37 (4.90%)
After-hours: Jun 20, 2025, 4:07 PM EDT
Aligos Therapeutics Market Cap
Aligos Therapeutics has a market cap or net worth of $46.17 million as of June 20, 2025. Its market cap has decreased by -1.49% in one year.
Market Cap
46.17M
Enterprise Value
-83.82M
1-Year Change
-1.49%
Ranking
Category
Stock Price
$7.55
Market Cap Chart
Since the IPO on October 16, 2020, Aligos Therapeutics's market cap has decreased from $553.35M to $46.17M, a decrease of -91.66%. That is a compound annual growth rate of -41.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 20, 2025 | 46.17M | -68.78% |
| Dec 31, 2024 | 147.87M | 197.20% |
| Dec 29, 2023 | 49.75M | 21.95% |
| Dec 30, 2022 | 40.80M | -91.93% |
| Dec 31, 2021 | 505.85M | -52.00% |
| Dec 31, 2020 | 1.05B | 90.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 704.75B |
| Johnson & Johnson | 362.67B |
| Novo Nordisk | 333.14B |
| AbbVie | 327.65B |
| UnitedHealth Group | 278.67B |
| Abbott Laboratories | 230.37B |
| Novartis AG | 227.73B |
| AstraZeneca | 219.65B |